Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14)

Neuroepidemiology

Volumn 28, Issue 1, 2007, Pages 50-55

  Hsu, Wei Chih ^a,b   Chiu, Yueh Hsia ^b   Chen, Wei Hung ^a   Chiu, Hou Chang ^a   Liou, Horng Huei ^d   Chen, Tony Hsiu Hsi ^b,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b Nat Inst Prev Med   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Diabetic polyneuropathy; Electrodiagnostic; Field study; Nerve conduction study

Indexed keywords

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FEMALE; FIELD STUDY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NERVE CONDUCTION DISORDER; PERONEUS NERVE; QUESTIONNAIRE; SCREENING; SENSORY NERVE CONDUCTION; STATISTICAL SIGNIFICANCE; SURAL NERVE;

ACTION POTENTIALS; ADULT; AGED; DIABETIC NEUROPATHIES; ELECTRODIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERONEAL NERVE; REACTION TIME; SENSITIVITY AND SPECIFICITY; SURAL NERVE;

EID: 33846862437     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098517     Document Type: Article

References (20)

1. Greene DA, Stevens MJ, Feldman EL: Diabetic neuropathy: scope of the syndrome. Am J Med 1999;107(2B):2S-8S.
2. Tomas PK: Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions. Eur Neurol 1999;41(suppl 1):35-43.
3. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes 1988;37:1000-1004.
4. Dyck PJ: Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988;11:21-32.
5. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ 3rd, O'Brien PC, et al: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799-807.
6. Dyck PJ, Milton LJ 3rd, O'Brien PC, Service FJ: Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester diabetic neuropathy study. Diabetes 1997;46(suppl 2):S5-S8.
7. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical twostep quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289.
8. Greene DA, Arezzo JC, Brown MB: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 1999;53:580-591.
9. Lehtinen JM, Uusitupa M, Sitonen O, Pyorala K: Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989;38:1307-1313.
10. Sima AAF, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, et al: Regeneration and repair of myelinated fibers in suralnerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988;319:548-555.
11. Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, et al;Taiwan Community-Based Integrated Screening Group: Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004;100:1734-1743.
12. Hsu WC, Chiu YC, Chiu HC, Liou HH, Jeng YC, Chen TH: Two-Stage Community-Based Screening Model for Estimating Prevalence of Diabetic Polyneuropathy (KCIS No. 6). Neuroepidemiology 2005;25:1-7.
13. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al: Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
14. Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, et al: Total neuropathy score: validation and reliability study. Neurology 1999;53:1660-1664.
15. De Wytt CN, Jackson RV, Hockings GI, Joyner JM, Strakosch CR: Polyneuropathy in Australian outpatients with type II diabetes mellitus. J Diabetes Complicat 1999;13:74-78.
16. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, et al: A multicenter study on the prevalence of diabetic neuropathy in Italy. Diabetes Care 1997;20:836-843.
17. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al: Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve 2005;31:113-123.
18. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG: Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997;20:1162-1167.
19. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O'Brien PC: Risk factors for severity of diabetic polyneuropathy. Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetic Care 1999;22:1479-1486.
20. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, et al: Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456-1461.